These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10888613)

  • 1. Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.
    Steigerwald-Mullen P; Kurilla MG; Braciale TJ
    J Virol; 2000 Aug; 74(15):6748-59. PubMed ID: 10888613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses.
    Leen A; Meij P; Redchenko I; Middeldorp J; Bloemena E; Rickinson A; Blake N
    J Virol; 2001 Sep; 75(18):8649-59. PubMed ID: 11507210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.
    Münz C; Bickham KL; Subklewe M; Tsang ML; Chahroudi A; Kurilla MG; Zhang D; O'Donnell M; Steinman RM
    J Exp Med; 2000 May; 191(10):1649-60. PubMed ID: 10811859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.
    Long HM; Chagoury OL; Leese AM; Ryan GB; James E; Morton LT; Abbott RJ; Sabbah S; Kwok W; Rickinson AB
    J Exp Med; 2013 May; 210(5):933-49. PubMed ID: 23569328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation.
    Nikiforow S; Bottomly K; Miller G; Münz C
    J Virol; 2003 Nov; 77(22):12088-104. PubMed ID: 14581546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.
    Heller KN; Upshaw J; Seyoum B; Zebroski H; Münz C
    Blood; 2007 Feb; 109(3):1138-46. PubMed ID: 16985171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.
    Precopio ML; Sullivan JL; Willard C; Somasundaran M; Luzuriaga K
    J Immunol; 2003 Mar; 170(5):2590-8. PubMed ID: 12594286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, and immunogenic characterization of Epstein-Barr virus recombinant EBNA1 protein in Pichia pastoris.
    Wang M; Jiang S; Liu X; Wang Y
    Appl Microbiol Biotechnol; 2013 Jul; 97(14):6251-62. PubMed ID: 23685476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis?
    Mameli G; Madeddu G; Cossu D; Galleri G; Manetti R; Babudieri S; Mura MS; Sechi LA
    Eur J Neurol; 2016 Jan; 23(1):140-7. PubMed ID: 26453465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.
    Bickham K; Münz C; Tsang ML; Larsson M; Fonteneau JF; Bhardwaj N; Steinman R
    J Clin Invest; 2001 Jan; 107(1):121-30. PubMed ID: 11134187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission.
    Marshall NA; Culligan DJ; Johnston PW; Millar C; Barker RN; Vickers MA
    Br J Haematol; 2007 Oct; 139(1):81-9. PubMed ID: 17854310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay.
    Calarota SA; Chiesa A; Zelini P; Comolli G; Minoli L; Baldanti F
    Immunology; 2013 Aug; 139(4):533-44. PubMed ID: 23560877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.
    Scherrenburg J; Piriou ER; Nanlohy NM; van Baarle D
    Clin Exp Immunol; 2008 Aug; 153(2):231-9. PubMed ID: 18549439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains.
    Brooks JM; Croom-Carter DS; Leese AM; Tierney RJ; Habeshaw G; Rickinson AB
    J Virol; 2000 Feb; 74(4):1801-9. PubMed ID: 10644353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
    Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
    J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis.
    Fischer F; Mücke J; Werny L; Gerrer K; Mihatsch L; Zehetmaier S; Riedel I; Geisperger J; Bodenhausen M; Schulte-Hillen L; Hoffmann D; Protzer U; Mautner J; Behrends U; Bauer T; Körber N
    Virol J; 2024 Jun; 21(1):139. PubMed ID: 38877590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1.
    Heller KN; Arrey F; Steinherz P; Portlock C; Chadburn A; Kelly K; Münz C
    Int J Cancer; 2008 Dec; 123(12):2824-31. PubMed ID: 18781564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.